Profusa, Inc. (PFSA)
1.70
+0.01
(+0.59%)
USD |
NASDAQ |
Oct 05, 13:40
Profusa EPS Diluted (Quarterly) : -151.80 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -151.80 |
| March 31, 2026 | -204.73 |
| December 31, 2025 | -695.32 |
| September 30, 2025 | -5245.35 |
| June 30, 2025 | -9100.58 |
| March 31, 2025 | -788190.7 |
| December 31, 2024 | -8713.58 |
| September 30, 2024 | -9661.35 |
| June 30, 2024 | -573.98 |
| March 31, 2024 | -1021.58 |
| Date | Value |
|---|---|
| December 31, 2023 | 293.62 |
| September 30, 2023 | -446.70 |
| June 30, 2023 | 1036.50 |
| March 31, 2023 | 150.52 |
| December 31, 2022 | 149.78 |
| September 30, 2022 | 547.35 |
| June 30, 2022 | 376.20 |
| March 31, 2022 | 1150.95 |
| December 31, 2021 | 93.30 |
| June 30, 2021 | -0.075 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Enovis Corp. | -0.0207 |
| Edwards Lifesciences Corp. | 0.4188 |
| IDEXX Laboratories, Inc. | 4.267 |
| Intuitive Surgical, Inc. | 2.290 |
| Kewaunee Scientific Corp. | 0.584 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.755M |
| Total Expenses (Quarterly) | 8.755M |
| Enterprise Value | 13.51M |
| Earnings Yield | -370.4K% |
| Normalized Earnings Yield | -369694.0 |